TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Aurena Laboratories Holding AB
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
284,588
|
251,809
|
208,291 |
| Financial expenses |
5,246
|
3,045
|
1,561 |
| Earnings before taxes |
25,406
|
19,367
|
13,031 |
| EBITDA |
39,632
|
29,721
|
19,557 |
| Total assets |
244,595
|
218,878
|
186,709 |
| Current assets |
104,404
|
87,888
|
85,942 |
| Current liabilities |
50,936
|
45,274
|
50,432 |
| Equity capital |
136,848
|
118,692
|
98,471 |
| - share capital |
516
|
507
|
473 |
| Employees (average) |
86
|
79
|
76 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
55.9%
|
54.2%
|
52.7% |
| Turnover per employee |
3,309
|
3,187
|
2,741 |
| Profit as a percentage of turnover |
8.9%
|
7.7%
|
6.3% |
| Return on assets (ROA) |
12.5%
|
10.2%
|
7.8% |
| Current ratio |
205.0%
|
194.1%
|
170.4% |
| Return on equity (ROE) |
18.6%
|
16.3%
|
13.2% |
| Change turnover |
28,238
|
28,739
|
24,898 |
| Change turnover % |
11%
|
13%
|
14% |
| Chg. No. of employees |
7
|
3
|
0 |
| Chg. No. of employees % |
9%
|
4%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.